We are Sorry, This Page doesn't Exist

Vertex Pharma (VRTX) is expected to beat estimates when it reports second-quarter earnings on Jul 25. We expect Vertex Pharmaceuticals, Inc. VRTX to beat expectations when it reports second-quarter 201.....»»

Vertex' (VRTX) Q3 gains on earnings and revenue beat with demand for its CF products rising high. Vertex Pharmaceuticals Incorporated VRTX announced third-quarter 2018 earnings per share of $1.09, which beat the Zacks Consensus Estimate of $1. .....»»

Zacks.....»»

  Shares of Vertex Energy (NASDAQ:VTNR) moved higher by 26.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 104.76% year over year to $0.01, which beat the estimate of ($0.01). read more.....»»

Vertex Pharmaceuticals Inc. shares rose in the extended session Thursday after the biotech drug maker's results and forecast topped Wall Street estimates. Vertex shares rose 2.9% after .....»»

Vertex Pharmaceuticals Incorporated (VRTX) CEO Jeff Leiden on Q3 2019 Results - Earnings Call Transcript.....»»

Zacks.....»»

Focus on reliability, resiliency and security through Energizing the Future plan is expected to drive FirstEne.....»»

Centene's (CNC) Q2 earnings are likely to be cushioned by higher revenues and membership. .....»»

Ameren (AEE) continues to implement its strategy of investing in rate-regulated energy infrastructure during the first quarter for improving its ove.....»»

FLEETCOR (FLT) first-quarter 2019 revenues likely to reflect strength across fuel, corporate pa.....»»

Investors are looking forward to the performance of Specialty Brands and other pipeline updates, when Mallinckrodt (MNK) reports Q1 results on May 7. .....»»

VRTX earnings call for the period ending March 31, 2019......»»

Vertex Pharmaceuticals Incorporated (VRTX) CEO Jeff Leiden on Q1 2019 Results - Earnings Call Transcript.....»»

On Vertex's (VRTX) first-quarter earnings call, investor focus will be on its latest CF drug Symdeko's sales figure as well as the update on its CF triple-pill r.....»»

New business wins for HCM software solutions might aid Paycom's (P.....»»

Our proven model does not show that Celanese (CE) is likely to beat.....»»

Centene's (CNC) Q1 earnings are likely to gain from its s.....»»

Accenture plc ACN is scheduled .....»»

Zacks.....»»